Biomerica, Inc. (BMRA)

Biomerica Income Statement

Financials in millions USD. Fiscal year is June - May.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 28, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020
Revenue	5.68	5.42	5.34	18.87	7.2	6.69
Revenue Growth (YoY)	5.01%	1.42%	-71.71%	162.13%	7.56%	28.69%
Cost of Revenue	4.92	4.8	4.89	15.89	6.83	4.91
Gross Profit	0.76	0.61	0.45	2.98	0.37	1.78
Selling, General & Admin	4.83	5.49	6.09	5.7	5.67	2.27
Research & Development	1.04	1.49	1.58	1.81	2.19	1.91
Operating Expenses	5.86	6.98	7.67	7.51	7.87	4.18
Operating Income	-5.1	-6.37	-7.22	-4.53	-7.5	-2.4
Interest Expense	-	-	-	-	-0	-0
Interest & Investment Income	0.25	0.43	0.13	0.03	0.07	0.07
Other Non Operating Income (Expenses)	-	-	0	-	-	-
Pretax Income	-4.85	-5.94	-7.09	-4.51	-7.43	-2.33
Income Tax Expense	0	0.04	0.05	0.02	0.01	0.01
Net Income	-4.85	-5.98	-7.14	-4.53	-7.45	-2.34
Net Income to Common	-4.85	-5.98	-7.14	-4.53	-7.45	-2.34
Shares Outstanding (Basic)	2	2	2	2	1	1
Shares Outstanding (Diluted)	2	2	2	2	1	1
Shares Change (YoY)	8.37%	18.84%	11.69%	6.24%	17.34%	10.35%
EPS (Basic)	-2.14	-2.84	-4.04	-2.86	-4.99	-1.84
EPS (Diluted)	-2.14	-2.88	-4.04	-2.88	-4.99	-1.84
Free Cash Flow	-4.25	-5.41	-5.54	-0.54	-5.39	-4.33
Free Cash Flow Per Share	-1.87	-2.57	-3.13	-0.34	-3.61	-3.41
Gross Margin	13.42%	11.28%	8.35%	15.78%	5.09%	26.62%
Operating Margin	-89.84%	-117.58%	-135.29%	-24.03%	-104.18%	-35.90%
Profit Margin	-85.42%	-110.40%	-133.73%	-24.01%	-103.43%	-34.95%
Free Cash Flow Margin	-74.81%	-99.94%	-103.73%	-2.84%	-74.84%	-64.71%
EBITDA	-5.02	-6.29	-7.14	-4.2	-7.36	-2.27
EBITDA Margin	-88.32%	-116.08%	-133.71%	-22.23%	-102.26%	-33.97%
D&A For EBITDA	0.09	0.08	0.08	0.34	0.14	0.13
EBIT	-5.1	-6.37	-7.22	-4.53	-7.5	-2.4
EBIT Margin	-89.84%	-117.58%	-135.29%	-24.03%	-104.18%	-35.90%
Advertising Expenses	-	0.1	0.16	0.08	0.01	0

Updated Jan 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q